News Sandoz, Teva and Mylan generics to be suspended in EU Regulator concerned over data from contract research organisation.
News Impax buys Teva and Allergan generics for $586 million Teva must sell some assets before buying Allergan's generics business.
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.